| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2018 | National survey of ABC (A1C, blood pressure, cholesterol) of Diabetes Health Promotion Institutes in Taiwan: 2002–2018 | Wang C.-Y.; Tu S.-T.; Sheu W.H.-H.; Chen I.-C.; Chuang L.-M.; Wu M.-S.; CHONG-JEN YU | Journal of the Formosan Medical Association | | | |
| 1995 | Nebulized fenoterol versus IV aminophylline treatment of acute severe asthma | Pan J.-F.; Yang P.-C.; Chang D.-B.; CHONG-JEN YU ; Lee L.-N.; Kuo S.-H. | American Journal of Emergency Medicine | | | |
| 2013 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer | Liao W.-Y.; Chen J.-H.; Wu M.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; CHONG-JEN YU | Clinical Lung Cancer | | | |
| 2020 | Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan | Chen Y.-M.; Chih-Hsin Yang J.; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; Ho C.-C.; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; CHONG-JEN YU | Journal of the Formosan Medical Association | | | |
| 2019 | NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility | Wu M.-F.; Shu C.-C.; Wang J.-Y.; Yan B.-S.; Lai H.-C.; Chiang B.-L.; Wu L.S.-H.; CHONG-JEN YU | Scientific Reports | | | |
| 2013 | Non-human immunodeficiency virus Pneumocystis jiroveci pneumonia | Chang C.-H.; Ruan S.-Y.; Li C.-C.; CHONG-JEN YU | Respirology | | | |
| 2019 | Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors | Chang L.-C.; Lim C.-K.; Chang L.-Y.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU | European Journal of Cancer | | | |
| 2011 | Non-surgical management of giant lung bullae during mechanical ventilation | Ruan S.-Y.; Huang C.-T.; Chien J.-Y.; Kuo Y.-W.; CHONG-JEN YU | Respiratory Care | | | |
| 2010 | Non-tuberculous mycobacterial pleurisy: An 8-year single-centre experience in Taiwan | Shu C.-C.; Lee L.-N.; Wang J.-T.; Chien Y.-J.; Wang J.-Y.; CHONG-JEN YU | International Journal of Tuberculosis and Lung Disease | | | |
| 2008 | Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: The incidence, patient characteristics, and clinical significance | Shu C.-C.; Lee C.-H.; Wang J.-Y.; Jerng J.-S.; CHONG-JEN YU ; Hsueh P.-R.; Lee L.-N.; Yang P.-C.; Wang J.-Y.; Lee L.-N.; CHONG-JEN YU ; Yang P.-C.; Su W.-J.; Shu C.-C.; Lai H.-C.; Lee C.-H.; Yu M.-C. | Intensive Care Medicine | | | |
| 2010 | Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors | Chen K.-Y.; Chen J.-H.; Shih J.-Y.; Yang C.-H.; CHONG-JEN YU ; Yang P.-C. | Journal of Thoracic Oncology | | | |
| 2013 | Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB | Chien J.-Y.; Chen Y.-T.; Shu C.-C.; Lee J.-J.; Wang J.-Y.; CHONG-JEN YU ; Yang P.-C. | Chest | | | |
| 2008 | Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment | Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU ; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. | Lung Cancer | | | |
| 2004 | Outcome of coal worker's pneumoconiosis with acute respiratory failure | Shen H.-N.; Jerng J.-S.; CHONG-JEN YU ; Yang P.-C. | Chest | | | |
| 2018 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study | Lin C.-C.; Shih J.-Y.; CHONG-JEN YU ; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. | The Lancet Respiratory Medicine | | | |
| 2017 | Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit | Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU | Journal of Cancer | | | |
| 2018 | Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors | Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; CHONG-JEN YU ; Chih-Hsin Yang J.; Yang P.-C. | Journal of the Formosan Medical Association | | | |
| 1996 | Overexpression of MUC5 genes is associated with early post-operative metastasis in non-small-cell lung cancer | CHONG-JEN YU ; Yang P.-C.; Shun C.-T.; Lee Y.-C.; Kuo S.-H.; Luh K.-T. | International Journal of Cancer | | | |
| 2004 | Overexpression of Placenta Growth Factor Contributes to the Pathogenesis of Pulmonary Emphysema | Tsao P.-N.; Su Y.-N.; Li H.; Huang P.-H.; Chien C.-T.; Lai Y.-L.; Lee C.-N.; Chen C.-A.; Cheng W.-F.; Wei S.-C.; CHONG-JEN YU ; Hsieh F.-J.; Hsu S.-M. | American Journal of Respiratory and Critical Care Medicine | | | |
| 2002 | Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a University Hospital, Taiwan | Hsueh P.-R.; Teng L.-J.; Chen C.-Y.; Chen W.-H.; CHONG-JEN YU ; Ho S.-W.; Luh K.-T. | Emerging Infectious Diseases | | | |
